[Initial experience with treatment of chronic hepatitis C in HIV-positive patients]

P Husa1, S Snopková, P Chalupa

  • 1Klinika infekcních chorob Lékarské fakulty MU a FN Brno, pracovistĕ Bohunice.

Vnitrni Lekarstvi
|August 23, 2003
PubMed

Insights

This study shows that while combined therapy can suppress Hepatitis C Virus (HCV) in HIV patients, relapse is common after treatment cessation. Further research is needed for sustained HCV clearance.

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Background:

  • A 30-year-old male with chronic Hepatitis C Virus (HCV) genotype 3 and Human Immunodeficiency Virus (HIV) infection presented for treatment.
  • The patient had a history of intravenous drug abuse, leading to his co-infection.

Observation:

  • HIV was stabilized with a three-drug antiretroviral therapy.
  • A 12-month course of combined alpha-interferon and ribavirin was initiated for chronic HCV genotype 3.

Findings:

  • HCV RNA and alanine aminotransferase (ALT) normalized during therapy.
  • Two months post-therapy, HCV RNA reappeared, and ALT levels increased, indicating relapse.
  • Therapy was generally well-tolerated, with ribavirin dose reduction managing a drop in hemoglobin.

Implications:

  • Combined therapy shows initial efficacy but limited long-term success for HCV genotype 3 in HIV co-infected patients.
  • Relapse necessitates exploring alternative or extended treatment strategies for sustained virologic response.
  • Managing treatment-related side effects, like anemia, is crucial for adherence and successful outcomes.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: